Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-10-29

Clinical Trial Update: Effects of Hesperidin on Bone Mineral Density and Bone Metabolism of Postmenopausal Women [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the effects of hesperidin on bone mineral density and bone metabolism in postmenopausal women with osteoporosis or osteopenia. The stud…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Hesperidin (Hesperidin)

Snippet

Sponsor: Société des Produits Nestlé (SPN) | Conditions: Osteoporosis, Osteopenia | Phase 3 | Status: COMPLETED